NIH 2020 R44 MH |
Objective, MRI biomarkers for pre-symptomatic detection of autism spectrum disorder at 6 months old: commercial software development and optimization Bower, Bradley A. / Primeneuro, Inc. |
|
NIH 2020 R44 MH |
Objective, MRI biomarkers for pre-symptomatic detection of autism spectrum disorder at 6 months old: commercial software development and optimization Bower, Bradley A. / Primeneuro, Inc. |
|
NIH 2018 R44 MH |
Objective, MRI biomarkers for pre-symptomatic detection of autism spectrum disorder at 6 months old: commercial software development and optimization Bower, Bradley A. / Primeneuro, Inc. |
|